Niraj Desai, MD
Ophthalmology · Cumming, GANPI 1508048802
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $116,083 of the $128,642 with a category attached, or 90.2%. Johnson & Johnson Surgical Vision, Inc. accounts for 91.9% of it on its own, with 23 other manufacturers making up the rest. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $574.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$118K
- Biotissue Holdings Inc.$4K
- Glaukos Corporation$3K
- Alcon$1K
- Rxsight Inc$461
- Amgen$298
- plus $2K from 18 others
What the payments were for
- Consulting fees$116,08390%
- Speaking & faculty fees$4,4903%
- Grants$1,0001%
- Travel & lodging$8401%
- Food & beverage$6,2105%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 108 | $118,179 |
| Biotissue Holdings Inc. | 10 | $3,974 |
| Glaukos Corporation | 10 | $2,515 |
| Alcon | 10 | $1,017 |
| Rxsight Inc | 7 | $461 |
| Amgen(2 entities) | 13 | $298 |
| Eyepoint US, Inc. | 3 | $278 |
| Novartis | 20 | $275 |
| NEW World Medical,inc. | 2 | $269 |
| Bausch & Lomb Americas Inc. | 8 | $164 |
| Sight Sciences, Inc. | 2 | $160 |
| Genentech USA, Inc. | 1 | $150 |
| Tarsus Pharmaceuticals, Inc. | 2 | $143 |
| AbbVie | 9 | $137 |
| Carl Zeiss Meditec USA, Inc. | 1 | $128 |
| Dompe US, Inc. | 4 | $103 |
| Oyster Point Pharma, Inc. | 4 | $101 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $70 |
| Sun Pharmaceutical Industries Inc. | 2 | $68 |
| Harrow Eye, LLC | 2 | $61 |
| Akorn Operating Company LLC | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Kala Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Simplicity$112,731
- Tecnis IOL$101,440
- Whitestar Signature Pro$27,435
- Prokera$3,750
- AmnioGraft$3,750
- AmnioGuard$3,750
- Whitestar Signature$1,750
- AXERT$840
- RXSIGHT CONTACT LENS$264
- RXSIGHT INJECTOR CARTRIDGE$264
- RXSIGHT INJECTOR HANDPIECE$264
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$264
- LIGHT ADJUSTABLE LENS (LAL)$264
- VERITAS Vision System$263
- LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE$262
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$262
- MEIBOMIAN GLAND EVALUATOR$262
- LIPIVIEW OCULAR SURFACE INTERFEROMETER$262
- DEXYCU$250
- Kahook Dual Blade$210
How this compares
$128,642 in reported general payments places this provider in the 95th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 20 | $21,638 |
| RestasisCyclosporine | 17 | $16,252 |
| Cyclosporine | 23 | $14,410 |
| Prednisolone Acetate | 163 | $7,133 |
| IlevroNepafenac | 19 | $6,965 |
| Bromfenac Sodium | 33 | $3,952 |
| ValacyclovirValacyclovir Hcl | 42 | $2,018 |
| MoxifloxacinMoxifloxacin Hcl | 82 | $1,910 |
| Latanoprost | 100 | $1,139 |
| Gatifloxacin | 25 | $1,064 |
| Brimonidine Tartrate | 24 | $328 |
| Timolol Maleate | 20 | $205 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $133 |
| Dorzolamide Hcl | 11 | $100 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $164 | $21,63820 claims |
| AbbVieRestasis | $137 | $16,25217 claims |
| NovartisIlevro | $275 | $6,96519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 481 ophthalmology providers in Georgia.
Other ophthalmology in Cumming
- Gregory LeeCumming$214K
- Byron CookCumming$29K
- Matthew KaufmanCumming$14K
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Jack ChapmanGainesville$244K
- Puneet PandaMarietta$185K
- Jeffrey TranSuwanee$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.